CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853899721
- Phone
- 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- S-1 Offering Registration Statement
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
Page 14 of 22 · 433 filings